300 related articles for article (PubMed ID: 23243202)
1. A prospective study of plasma adiponectin and pancreatic cancer risk in five US cohorts.
Bao Y; Giovannucci EL; Kraft P; Stampfer MJ; Ogino S; Ma J; Buring JE; Sesso HD; Lee IM; Gaziano JM; Rifai N; Pollak MN; Cochrane BB; Kaklamani V; Lin JH; Manson JE; Fuchs CS; Wolpin BM
J Natl Cancer Inst; 2013 Jan; 105(2):95-103. PubMed ID: 23243202
[TBL] [Abstract][Full Text] [Related]
2. Low plasma adiponectin levels and risk of colorectal cancer in men: a prospective study.
Wei EK; Giovannucci E; Fuchs CS; Willett WC; Mantzoros CS
J Natl Cancer Inst; 2005 Nov; 97(22):1688-94. PubMed ID: 16288122
[TBL] [Abstract][Full Text] [Related]
3. Prediagnostic adiponectin concentrations and pancreatic cancer risk in male smokers.
Stolzenberg-Solomon RZ; Weinstein S; Pollak M; Tao Y; Taylor PR; Virtamo J; Albanes D
Am J Epidemiol; 2008 Nov; 168(9):1047-55. PubMed ID: 18801887
[TBL] [Abstract][Full Text] [Related]
4. Plasma 25-hydroxyvitamin D and risk of pancreatic cancer.
Wolpin BM; Ng K; Bao Y; Kraft P; Stampfer MJ; Michaud DS; Ma J; Buring JE; Sesso HD; Lee IM; Rifai N; Cochrane BB; Wactawski-Wende J; Chlebowski RT; Willett WC; Manson JE; Giovannucci EL; Fuchs CS
Cancer Epidemiol Biomarkers Prev; 2012 Jan; 21(1):82-91. PubMed ID: 22086883
[TBL] [Abstract][Full Text] [Related]
5. Inflammatory plasma markers and pancreatic cancer risk: a prospective study of five U.S. cohorts.
Bao Y; Giovannucci EL; Kraft P; Qian ZR; Wu C; Ogino S; Gaziano JM; Stampfer MJ; Ma J; Buring JE; Sesso HD; Lee IM; Rifai N; Pollak MN; Jiao L; Lessin L; Cochrane BB; Manson JE; Fuchs CS; Wolpin BM
Cancer Epidemiol Biomarkers Prev; 2013 May; 22(5):855-61. PubMed ID: 23462920
[TBL] [Abstract][Full Text] [Related]
6. Prediagnosis Plasma Adiponectin in Relation to Colorectal Cancer Risk According to KRAS Mutation Status.
Inamura K; Song M; Jung S; Nishihara R; Yamauchi M; Lochhead P; Qian ZR; Kim SA; Mima K; Sukawa Y; Masuda A; Imamura Y; Zhang X; Pollak MN; Mantzoros CS; Harris CC; Giovannucci E; Fuchs CS; Cho E; Chan AT; Wu K; Ogino S
J Natl Cancer Inst; 2016 Apr; 108(4):. PubMed ID: 26598515
[TBL] [Abstract][Full Text] [Related]
7. Serum C-peptide, Total and High Molecular Weight Adiponectin, and Pancreatic Cancer: Do Associations Differ by Smoking?
Nogueira LM; Newton CC; Pollak M; Silverman DT; Albanes D; Männistö S; Weinstein SJ; Jacobs EJ; Stolzenberg-Solomon RZ
Cancer Epidemiol Biomarkers Prev; 2017 Jun; 26(6):914-922. PubMed ID: 28096201
[No Abstract] [Full Text] [Related]
8. Hyperglycemia, insulin resistance, impaired pancreatic β-cell function, and risk of pancreatic cancer.
Wolpin BM; Bao Y; Qian ZR; Wu C; Kraft P; Ogino S; Stampfer MJ; Sato K; Ma J; Buring JE; Sesso HD; Lee IM; Gaziano JM; McTiernan A; Phillips LS; Cochrane BB; Pollak MN; Manson JE; Giovannucci EL; Fuchs CS
J Natl Cancer Inst; 2013 Jul; 105(14):1027-35. PubMed ID: 23847240
[TBL] [Abstract][Full Text] [Related]
9. A prospective study of plasma C-peptide and colorectal cancer risk in men.
Ma J; Giovannucci E; Pollak M; Leavitt A; Tao Y; Gaziano JM; Stampfer MJ
J Natl Cancer Inst; 2004 Apr; 96(7):546-53. PubMed ID: 15069117
[TBL] [Abstract][Full Text] [Related]
10. Circulating Leptin and Risk of Pancreatic Cancer: A Pooled Analysis From 3 Cohorts.
Stolzenberg-Solomon RZ; Newton CC; Silverman DT; Pollak M; Nogueira LM; Weinstein SJ; Albanes D; Männistö S; Jacobs EJ
Am J Epidemiol; 2015 Aug; 182(3):187-97. PubMed ID: 26085045
[TBL] [Abstract][Full Text] [Related]
11. The association of circulating adiponectin levels with pancreatic cancer risk: a study within the prospective EPIC cohort.
Grote VA; Rohrmann S; Dossus L; Nieters A; Halkjaer J; Tjønneland A; Overvad K; Stegger J; Chabbert-Buffet N; Boutron-Ruault MC; Clavel-Chapelon F; Teucher B; Becker S; Montonen J; Boeing H; Trichopoulou A; Lagiou P; Trichopoulos D; Palli D; Sieri S; Tumino R; Vineis P; Mattiello A; Argüelles M; Duell EJ; Molina-Montes E; Larrañaga N; Chirlaque MD; Gurrea AB; Jeurnink SM; Peeters PH; Ye W; Sund M; Lindkvist B; Johansen D; Khaw KT; Wareham N; Crowe FL; Romieu I; Rinaldi S; Jenab M; Romaguera D; Michaud DS; Riboli E; Bas Bueno-de-Mesquita H; Kaaks R
Int J Cancer; 2012 May; 130(10):2428-37. PubMed ID: 21681743
[TBL] [Abstract][Full Text] [Related]
12. A prospective study of soluble receptor for advanced glycation end products and adipokines in association with pancreatic cancer in postmenopausal women.
White DL; Hoogeveen RC; Chen L; Richardson P; Ravishankar M; Shah P; Tinker L; Rohan T; Whitsel EA; El-Serag HB; Jiao L
Cancer Med; 2018 May; 7(5):2180-2191. PubMed ID: 29573228
[TBL] [Abstract][Full Text] [Related]
13. Association between plasma adiponectin levels and colorectal cancer risk in women.
Chandler PD; Buring JE; Manson JE; Moorthy MV; Zhang S; Lee IM; Lin JH
Cancer Causes Control; 2015 Jul; 26(7):1047-52. PubMed ID: 25941065
[TBL] [Abstract][Full Text] [Related]
14. Circulating insulin-like growth factor binding protein-1 and the risk of pancreatic cancer.
Wolpin BM; Michaud DS; Giovannucci EL; Schernhammer ES; Stampfer MJ; Manson JE; Cochrane BB; Rohan TE; Ma J; Pollak MN; Fuchs CS
Cancer Res; 2007 Aug; 67(16):7923-8. PubMed ID: 17699799
[TBL] [Abstract][Full Text] [Related]
15. Serum transforming growth factor-β1 and risk of pancreatic cancer in three prospective cohort studies.
Jacobs EJ; Newton CC; Silverman DT; Nogueira LM; Albanes D; Männistö S; Pollak M; Stolzenberg-Solomon RZ
Cancer Causes Control; 2014 Sep; 25(9):1083-91. PubMed ID: 24913781
[TBL] [Abstract][Full Text] [Related]
16. Regular Use of Aspirin or Non-Aspirin Nonsteroidal Anti-Inflammatory Drugs Is Not Associated With Risk of Incident Pancreatic Cancer in Two Large Cohort Studies.
Khalaf N; Yuan C; Hamada T; Cao Y; Babic A; Morales-Oyarvide V; Kraft P; Ng K; Giovannucci E; Ogino S; Stampfer M; Cochrane BB; Manson JE; Clish CB; Chan AT; Fuchs CS; Wolpin BM
Gastroenterology; 2018 Apr; 154(5):1380-1390.e5. PubMed ID: 29229401
[TBL] [Abstract][Full Text] [Related]
17. Leucocyte telomere length, genetic variants at the
Bao Y; Prescott J; Yuan C; Zhang M; Kraft P; Babic A; Morales-Oyarvide V; Qian ZR; Buring JE; Cochrane BB; Gaziano JM; Giovannucci EL; Manson JE; Ng K; Ogino S; Rohan TE; Sesso HD; Stampfer MJ; Fuchs CS; De Vivo I; Amundadottir LT; Wolpin BM
Gut; 2017 Jun; 66(6):1116-1122. PubMed ID: 27797938
[TBL] [Abstract][Full Text] [Related]
18. A U-shaped relationship between plasma folate and pancreatic cancer risk in the European Prospective Investigation into Cancer and Nutrition.
Chuang SC; Stolzenberg-Solomon R; Ueland PM; Vollset SE; Midttun Ø; Olsen A; Tjønneland A; Overvad K; Boutron-Ruault MC; Morois S; Clavel-Chapelon F; Teucher B; Kaaks R; Weikert C; Boeing H; Trichopoulou A; Benetou V; Naska A; Jenab M; Slimani N; Romieu I; Michaud DS; Palli D; Sieri S; Panico S; Sacerdote C; Tumino R; Skeie G; Duell EJ; Rodriguez L; Molina-Montes E; Huerta JM; Larrañaga N; Gurrea AB; Johansen D; Manjer J; Ye W; Sund M; Peeters PH; Jeurnink S; Wareham N; Khaw KT; Crowe F; Riboli E; Bueno-de-Mesquita B; Vineis P
Eur J Cancer; 2011 Aug; 47(12):1808-16. PubMed ID: 21411310
[TBL] [Abstract][Full Text] [Related]
19. Pancreatic Cancer Risk Associated with Prediagnostic Plasma Levels of Leptin and Leptin Receptor Genetic Polymorphisms.
Babic A; Bao Y; Qian ZR; Yuan C; Giovannucci EL; Aschard H; Kraft P; Amundadottir LT; Stolzenberg-Solomon R; Morales-Oyarvide V; Ng K; Stampfer MJ; Ogino S; Buring JE; Sesso HD; Gaziano JM; Rifai N; Pollak MN; Anderson ML; Cochrane BB; Luo J; Manson JE; Fuchs CS; Wolpin BM
Cancer Res; 2016 Dec; 76(24):7160-7167. PubMed ID: 27780823
[TBL] [Abstract][Full Text] [Related]
20. Plasma adipokines and endometriosis risk: a prospective nested case-control investigation from the Nurses' Health Study II.
Shah DK; Correia KF; Harris HR; Missmer SA
Hum Reprod; 2013 Feb; 28(2):315-21. PubMed ID: 23188112
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
